Efficacy and safety of mavacamten in treatment of hypertrophic cardiomyopathy: a systematic review and meta-analysis

AIM: This meta-analysis was performed to assess the efficacy and safety of mavacamten in patients with hypertrophic cardiomyopathy. METHODS & MATERIALS: A search was conducted using PubMed, Cochrane, and Scopus up to August 2022 for randomized studies reporting our pre-specified outcomes. RESULT...

Descripción completa

Detalles Bibliográficos
Autores principales: Memon, Areeba, Larik, Muhammad Omar, Khan, Zoha, Urooj, Maryam, Irfan, Areeka, Kumari, Beena, Faisal, Mehak, Siddiqui, Rida, Tehrim, Moniba, Hameed, Ishaque
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2023
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518811/
https://www.ncbi.nlm.nih.gov/pubmed/37753355
http://dx.doi.org/10.2144/fsoa-2023-0059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518811/
https://www.ncbi.nlm.nih.gov/pubmed/37753355
http://dx.doi.org/10.2144/fsoa-2023-0059

Ejemplares similares